Granted Orphan designation by the FDA as a conditioning treatment for use in autologous transplant for patients with multiple myeloma.
http://eon.businesswire.com/news/eon/20131030005212/en/Spectrum-Pharmaceuticals-Announces-Completion-Enrollment-Pivotal-Trial
http://eon.businesswire.com/news/eon/20131030005212/en/Spectrum-Pharmaceuticals-Announces-Completion-Enrollment-Pivotal-Trial
No comments:
Post a Comment